adamantane has been researched along with glycine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bigalke, H; Lampe, H | 1 |
| Alberti, E; Gil, AM | 1 |
| Khodorov, BI; Koshelev, SG; Sobolevsky, AI | 1 |
| Abboa-Offei, B; Augeri, DJ; Betebenner, DA; Biller, SA; Cap, M; Chang, SY; Egan, DM; Hamann, LG; Han, SP; Huang, Q; Khanna, A; Kirby, MS; Magnin, DR; Marcinkeviciene, J; Parker, RA; Robertson, JG; Robl, JA; Simpkins, LM; Tao, L; Taunk, P; Tozzo, E; Wang, A; Welzel, GE; Xin, L | 1 |
| Lebovitz, H | 1 |
| Heinzl, S | 1 |
| Davies, HM; Lee, GH; Reddy, RP | 1 |
| Davies, HM; Reddy, RP | 1 |
| Clay, WC; Dean, DK; Michel, AD; Ng, SW; Roman, S; Walter, DS | 1 |
| Fink, G; Martineau, C; Steuernagel, S; Suzuki, K; Taulelle, F | 1 |
| Asfar, P; Collin, S; Fremont-Orlowski, S; Ganster, F; Issa, K; Kimmoun, A; Levy, B; Mertes, PM | 1 |
| Aliev, AE; Courtier-Murias, D | 1 |
2 review(s) available for adamantane and glycine
| Article | Year |
|---|---|
Diabetes: assessing the pipeline.
Topics: Adamantane; Alkanesulfonates; Amyloid; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Exenatide; Glycine; Humans; Hypoglycemic Agents; Indoles; Islet Amyloid Polypeptide; Maleimides; Nitriles; Oxazoles; Peptides; Phenylpropionates; Piperidines; PPAR alpha; PPAR gamma; Protein Kinase C; Pyrazoles; Pyrrolidines; Receptor, Cannabinoid, CB1; Receptors, Glucagon; Rimonabant; Venoms; Vildagliptin | 2006 |
[Dipeptidylpeptidase IV inhibitors and dual action PPAR-agonists].
Topics: Adamantane; Adenosine Deaminase Inhibitors; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Glycine; Glycoproteins; Humans; Hypoglycemic Agents; Nitriles; Oxazoles; Peroxisome Proliferator-Activated Receptors; Protease Inhibitors; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Triazoles; Vildagliptin | 2006 |
10 other study(ies) available for adamantane and glycine
| Article | Year |
|---|---|
Modulation of glycine-activated membrane current by adamantane derivatives.
Topics: Adamantane; Amantadine; Animals; Cell Membrane; Cells, Cultured; Chloride Channels; Fetus; gamma-Aminobutyric Acid; Glycine; Ion Channels; Membrane Potentials; Membrane Proteins; Mice; Neurons; Spinal Cord | 1991 |
The effect of Magic Angle Spinning on proton spin-lattice relaxation times in some organic solids.
Topics: Adamantane; Glycine; Humans; Magnetic Resonance Spectroscopy; Protons | 1998 |
Molecular size and hydrophobicity as factors which determine the efficacy of the blocking action of amino-adamantane derivatives on NMDA channels.
Topics: Adamantane; Animals; Aspartic Acid; Electrophysiology; Glycine; Hippocampus; Ion Channels; Neurons; Rats; Receptors, N-Methyl-D-Aspartate | 1999 |
Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Topics: Adamantane; Animals; Biological Availability; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl Peptidase 4; Glucose Tolerance Test; Glycine; Humans; Hypoglycemic Agents; In Vitro Techniques; Insulin; Male; Mice; Mice, Obese; Microsomes, Liver; Nitriles; Proline; Protease Inhibitors; Rats; Rats, Zucker; Stereoisomerism; Structure-Activity Relationship | 2005 |
Dirhodium tetracarboxylate derived from adamantylglycine as a chiral catalyst for carbenoid reactions.
Topics: Adamantane; Catalysis; Glycine; Molecular Structure; Organometallic Compounds; Rhodium; Stereoisomerism | 2006 |
Dirhodium tetracarboxylates derived from adamantylglycine as chiral catalysts for enantioselective C-h aminations.
Topics: Adamantane; Amination; Catalysis; Glycine; Molecular Structure; Organometallic Compounds; Rhodium; Stereoisomerism | 2006 |
Mechanism of action of species-selective P2X(7) receptor antagonists.
Topics: Adamantane; Adenosine Triphosphate; Animals; Azabicyclo Compounds; Binding Sites; Cell Line, Tumor; Dogs; Dose-Response Relationship, Drug; Glycine; Guinea Pigs; Humans; Mice; Piperazines; Protein Conformation; Purinergic P2 Receptor Antagonists; Radioligand Assay; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Recombinant Fusion Proteins; Recombinant Proteins; Species Specificity; Structure-Activity Relationship; Temperature; Thiazoles; Transduction, Genetic; Vanadates | 2009 |
Hartmann-Hahn 2D-map to optimize the RAMP-CPMAS NMR experiment for pharmaceutical materials.
Topics: Adamantane; Data Interpretation, Statistical; Glycine; Ibuprofen; Nuclear Magnetic Resonance, Biomolecular; Protons; Radio Waves; Signal-To-Noise Ratio | 2012 |
Compared effects of inhibition and exogenous administration of hydrogen sulphide in ischaemia-reperfusion injury.
Topics: Acidosis, Lactic; Adamantane; Adenosine Triphosphate; Alkynes; Animals; Cytokines; Disease Models, Animal; Gasotransmitters; Glycine; Hemodynamics; Hydrogen Sulfide; KATP Channels; Male; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Morpholines; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Norepinephrine; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats, Wistar; Reperfusion Injury; Shock, Hemorrhagic; Sulfides; Up-Regulation; Vasoconstrictor Agents | 2013 |
Concise NMR approach for molecular dynamics characterizations in organic solids.
Topics: Adamantane; Dipeptides; Glycine; Magnetic Resonance Spectroscopy; Methenamine; Models, Molecular; Molecular Dynamics Simulation; Proline | 2013 |